ABY-062

N/A

Report date: 2025/01/26 18:30:19

Base Information

Drug NameABY-062
Drug Alias NameThymic stromal lymphopoietin ligand inhibitor (Affibody)ABY-062
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionThymic stromal lymphopoietin inhibitors
TargetsThymic stromal lymphopoietin
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesAffibody Medical AB
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A